Pre-cleared export lines with certified GC-MS profiles, fully compatible with respiratory inhalation therapies, mucolytic balms, and pharmaceutical excipient blending.
Standardizing 1,8-cineole (eucalyptol) chemistry for mucociliary clearance, inflammation suppression, and bronchial spasm relief.
Eucalyptol acts as a potent inhibitor of arachidonic acid metabolism, blocking downstream tumor necrosis factor-alpha (TNF-α) and leukotriene B4 (LTB4) synthesis. This molecular mechanism leads to rapid reduction in airway hyperresponsiveness and smooth muscle constriction.
In acute or chronic bronchial inflammation, excess viscous mucus severely limits peak expiratory flow. Pharmacopoeial eucalyptus oil stimulates bronchial ciliary beat frequency (CBF), accelerating surfactant production and improving expectoration without stimulating systemic tachycardia.
Clinical data validate that controlled inhalation or encapsulated oral administration of cineole fractions allows glucocorticoid dose reduction by up to 36% in patients with stable bronchial asthma, serving as a validated phyto-therapeutic co-treatment.
Combining local raw botanical harvesting economics with European cGMP compliant processing lines.
Our extraction campus is located directly within Jiangxi's primary forestry zone, yielding sustainable wild and farm-harvested Eucalyptus globulus feedstock with zero transshipment degradation.
Unlike atmospheric pot distillers, our 6 essential oil lines feature multi-stage vacuum fractional rectification to refine crude eucalyptus oil (60%) up to pharmaceutical-grade 80% to 85% eucalyptol purities.
Every industrial run is screened by Shimadzu GC-MS and Waters HPLC for residual heavy metals (<0.5 ppm), volatile solvents, and chlorinated terpenes, meeting strict pharmacopoeial limits.
Direct pipeline supply into 25kg fluorinated HDPE carboys, 180kg epoxy-lined steel drums, or automated filling of amber dropper bottles for private-label brands across North America, Europe, and Asia.
Reference wholesale indices based on contract volume, packaging requirements, and pharmaceutical monograph compliance.
| Grade Designation | Assay (1,8-Cineole) | Refractive Index (20°C) | Compliance Standard | MOQ | Indicative Price (FOB Ningbo/Shanghai) |
|---|---|---|---|---|---|
| Technical/Aroma Grade | 60.0% – 65.0% | 1.458 – 1.465 | ISO 3065 / Industrial | 100 kg | $12.50 – $15.00 / kg |
| Cosmetic/Diffuser Grade | 70.0% – 75.0% | 1.459 – 1.466 | IFRA / REACH Registered | 50 kg | $16.80 – $19.50 / kg |
| Pharma-Standard (EP/BP) | ≥ 80.0% | 1.458 – 1.467 | European Pharmacopoeia (EP 10.0) | 25 kg | $21.50 – $25.00 / kg |
| Ultra-Purified Clinical API | ≥ 85.0% – 99.0% | 1.457 – 1.462 | USP / cGMP Monograph Verified | 25 kg | $28.00 – $34.50 / kg |
*Official pricelists adjust based on quarterly feedstock yields, ocean freight, and custom distillation contracts. Inquire for current CIF spot pricing.
Overcoming regional compliance hurdles for respiratory therapeutic products through comprehensive documentation and quality guarantees.
For bronchial relief products and aromatherapy medical devices in the EU, Baicao provides complete REACH dossiers, IFRA 51st Amendment certificates, allergen screening sheets (confirming limonene levels <1.5%), and Traditional Herbal Medicinal Product (THMPD) compliant documentation.
Our essential oils are processed in FDA-registered cleanrooms. For manufacturers formulating OTC respiratory vaporizing ointments or inhalation inhalant capsules under 21 CFR Part 341, we assist with Active Substance Master File (ASMF) and Drug Master File (DMF) technical paperwork.
Every commercial consignment ships with lot-traceable documentation: Shimadzu GC-MS Chromatogram, Certificate of Analysis (COA), 16-Section GHS-compliant SDS, Non-GMO verification, Certificate of Origin, and BSE/TSE declaration forms for seamless customs clearance.
The convergence of plant-derived medicines and modern pulmonary healthcare applications.
Global pharmaceutical brands are moving away from petrochemical excipients. High-assay 1,8-cineole is increasingly replacing synthetic decongestants in chest rubs, vapor patches, and sauna therapy blends due to its proven mucolytic performance and consumer preference for botanical origins.
A growing application trend involves microencapsulating pure eucalyptus terpenes into enteric-coated softgels for lower respiratory tract delivery, minimizing gastric irritation while ensuring controlled release directly to systemic circulation.
Medical device companies partner with us to supply water-dispersible micro-emulsions of purified eucalyptol for specialized clinical nebulizers and home steam dispensers, offering rapid therapeutic dispersion during seasonal asthmatic peaks.
Key information on distillation processes, technical compliance, and international order fulfillment.
Pair high-potency eucalyptus distillates with certified carrier oils, antimicrobial bases, and calming botanical extracts for complete respiratory product lines.